RRC ID 44059
著者 Gotoh A, Kanno T, Nagaya H, Nakano T, Tabata C, Fukuoka K, Tagawa M, Nishizaki T.
タイトル Gene therapy using adenovirus against malignant mesothelioma.
ジャーナル Anticancer Res
Abstract BACKGROUND:Adenovirus vectors have been utilized for cancer gene therapies. The present study examined the oncolytic effects of adenovirus type 5 (Ad5) and fiber-substituted conditionally replicating adenovirus (CRAD) Ad5/F35 vectors on the human malignant mesothelioma cells MSTO-211H, NCI-H28, NCI-H2052, and NCI-H2452 cells.
MATERIALS AND METHOD:For the adenovirus, the first mRNA/protein to be made (~1 h after infection) is E1A. Ad5F35 and Ad5 CRAD vectors containing the E1 gene controlled by the human midkine promoter (Ad5F35/MKp-E1 and Ad5/MKp-E1, respectively) were constructed. Western blotting and cell viability assays were carried out in cells transfected with Ad5/MKp-E1 and Ad5F35/MKp-E1.
RESULTS:Coxsackie and adenovirus receptor (CAR), a cell surface target of Ad5, and CD46, a cell surface target of Ad35, were expressed in all the malignant mesothelioma cell lines examined here, as much as in HEK293 cells, with no significant differences in the expression levels among cells. Both Ad5/MKp-E1 and Ad5F35/MKp-E1 induced oncolysis of malignant mesothelioma cells in a viral particle-dependent manner, with similar efficacy.
CONCLUSION:The results of the present study suggest that both Ad5/MKp-E1 and Ad5F35/MKp-E1 are useful for the gene therapy of human malignant mesothelioma.
巻・号 32(9)
ページ 3743-7
公開日 2012-9-1
PII 32/9/3743
PMID 22993314
MeSH Adenovirus E1 Proteins / genetics Adenoviruses, Human / genetics Adenoviruses, Human / physiology* Cell Line, Tumor Coxsackie and Adenovirus Receptor-Like Membrane Protein / biosynthesis Genetic Therapy / methods* HEK293 Cells Humans Lung Neoplasms / genetics* Lung Neoplasms / therapy* Lung Neoplasms / virology Membrane Cofactor Protein / biosynthesis Mesothelioma / genetics* Mesothelioma / therapy* Mesothelioma / virology Mesothelioma, Malignant Midkine Nerve Growth Factors / genetics Oncolytic Virotherapy / methods* Promoter Regions, Genetic Transfection Virus Replication
IF 1.994
引用数 4
WOS 分野 ONCOLOGY
リソース情報
ヒト・動物細胞